{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T14:16:25Z","timestamp":1784556985710,"version":"3.55.0"},"reference-count":6,"publisher":"Bioscientifica","issue":"7","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["ec.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,7]]},"abstract":"<jats:p>Cranial diabetes insipidus (CDI) is a treatable chronic condition that can potentially develop into a life-threatening medical emergency. CDI is due to the relative or absolute lack of the posterior pituitary hormone vasopressin (AVP), also known as anti-diuretic hormone. AVP deficiency results in uncontrolled diuresis. Complete deficiency can lead to polyuria exceeding 10\u2009L\/24\u2009h. Given a functioning thirst mechanism and free access to water, patients with CDI can normally maintain adequate fluid balance through increased drinking. Desmopressin (DDAVP, a synthetic AVP analogue) reduces uncontrolled water excretion in CDI and is commonly used in treatment. Critically, loss of thirst perception (through primary pathology or reduced consciousness) or limited access to water (through non-availability, disability or inter-current illness) in a patient with CDI can lead to life-threatening dehydration. This position can be further exacerbated through the omission of DDAVP. Recent data have highlighted serious adverse events (including deaths) in patients with CDI. These adverse outcomes and deaths have occurred through a combination of lack of knowledge and treatment failures by health professionals. Here, with our guideline, we recommend treatment pathways for patients with known CDI admitted to hospital. Following these guidelines is essential for the safe management of patients with CDI.<\/jats:p>","DOI":"10.1530\/ec-18-0154","type":"journal-article","created":{"date-parts":[[2018,6,21]],"date-time":"2018-06-21T10:35:11Z","timestamp":1529577311000},"page":"G8-G11","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-10","source":"Crossref","is-referenced-by-count":59,"title":["SOCIETY FOR ENDOCRINOLOGY CLINICAL GUIDANCE: Inpatient management of cranial diabetes insipidus"],"prefix":"10.1530","volume":"7","author":[{"given":"S E","family":"Baldeweg","sequence":"first","affiliation":[{"name":"1Department of Diabetes and Endocrinology, University College London NHS Foundation Trust and Univeristy College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Ball","sequence":"additional","affiliation":[{"name":"2Department of Medicine and Endocrinology, Manchester University Foundation Trust & Manchester Academic Health Science Centre Manchester, Manchester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Brooke","sequence":"additional","affiliation":[{"name":"3Royal Devon and Exeter NHS Foundation Trust, Exeter, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H K","family":"Gleeson","sequence":"additional","affiliation":[{"name":"4Department of Endocrinology, Queen Elizabeth Hospital, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M J","family":"Levy","sequence":"additional","affiliation":[{"name":"5University of Leicester and University of Leicester Hospitals Trust, Leicester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Prentice","sequence":"additional","affiliation":[{"name":"6Croydon Health Services NHS Trust, Croydon, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Wass","sequence":"additional","affiliation":[{"name":"7Department of Endocrinology, Oxford Centre for Diabetes, Endocrinology & Metabolism, Oxford, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"_","family":"_","sequence":"additional","affiliation":[{"name":"8The Society for Endocrinology, Starling House, 1600 Bristol Parkway North, Bristol, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"ref31","doi-asserted-by":"publisher","first-page":"20165","DOI":"10.1530\/EC-16-0058","article-title":"BallSBarthJLevyM for Endocrinology Clinical Committee for Endocrine Emergency Guidance management of severe symptomatic hyponatraemia in adult patients Connections https org","journal-title":"Society Society Endocrinology Emergency Endocrine"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"20165","DOI":"10.1530\/EC-16-0058","article-title":"BallSBarthJLevyM for Endocrinology Clinical Committee for Endocrine Emergency Guidance management of severe symptomatic hyponatraemia in adult patients Connections https org","journal-title":"Society Society Endocrinology Emergency Endocrine"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1210\/jc.2016-2118","article-title":"Hormonal replacement in hypopituitarism in adults: an Endocrine Society Clinical Practice Guideline","volume":"101","year":"2016","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"20165","DOI":"10.1530\/EC-16-0054","article-title":"The for Clinical Committee for Endocrine Emergency Guidance Emergency management of acute adrenal insufficiency adrenal crisis in adult patients Connections https org","author":"ArltW","journal-title":"Society Endocrinology Society Endocrinology Endocrine"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"20165","DOI":"10.1530\/EC-16-0054","article-title":"The for Clinical Committee for Endocrine Emergency Guidance Emergency management of acute adrenal insufficiency adrenal crisis in adult patients Connections https org","author":"ArltW","journal-title":"Society Endocrinology Society Endocrinology Endocrine"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1210\/jc.2016-2118","article-title":"Hormonal replacement in hypopituitarism in adults: an Endocrine Society Clinical Practice Guideline","volume":"101","year":"2016","journal-title":"Journal of Clinical Endocrinology and Metabolism"}],"container-title":["Endocrine Connections"],"original-title":[],"link":[{"URL":"https:\/\/ec.bioscientifica.com\/view\/journals\/ec\/7\/7\/EC-18-0154.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ec.bioscientifica.com\/downloadpdf\/journals\/ec\/7\/7\/EC-18-0154.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:42:54Z","timestamp":1784554974000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.bioscientifica.com\/ec\/article\/7\/7\/G8-G11\/338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":6,"journal-issue":{"issue":"7"},"URL":"https:\/\/doi.org\/10.1530\/ec-18-0154","relation":{},"ISSN":["2049-3614"],"issn-type":[{"value":"2049-3614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7]]}}}